Cargando…
Investigating the role of c-Jun N-terminal kinases in the proliferation of Werner syndrome fibroblasts using diaminopyridine inhibitors
Fibroblasts derived from the progeroid Werner syndrome show reduced replicative lifespan and a "stressed" morphology, both alleviated using the MAP kinase inhibitor SB203580. However, interpretation of these data is problematical because although SB203580 has the stress-activated kinases p...
Autores principales: | Davis, Terence, Dix, Matthew C, Rokicki, Michal J, Brook, Amy JC, Widdowson, Caroline S, Kipling, David, Bagley, Mark C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262757/ https://www.ncbi.nlm.nih.gov/pubmed/22152108 http://dx.doi.org/10.1186/1752-153X-5-83 |
Ejemplares similares
-
The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome
por: Davis, Terence, et al.
Publicado: (2013) -
Evaluating the Role of p38 MAPK in the Accelerated Cell Senescence of Werner Syndrome Fibroblasts
por: Davis, Terence, et al.
Publicado: (2016) -
Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome
por: Bagley, Mark C., et al.
Publicado: (2010) -
Activation of p38 MAP kinase and stress signalling in fibroblasts from the progeroid Rothmund–Thomson syndrome
por: Davis, Terence, et al.
Publicado: (2012) -
Small Molecule Inhibition of p38 MAP Kinase Extends the Replicative Life Span of Human ATR-Seckel Syndrome Fibroblasts
por: Tivey, Hannah S. E., et al.
Publicado: (2013)